High Grade Serous | List of Frontiers open access articles

Original Research

Published on 05 Mar 2021

Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer

in Women's Cancer

Nicole E. James
Katherine Miller
Natalie LaFranzo
Erin Lips
Morgan Woodman
Joyce Ou
Jennifer R. Ribeiro

Frontiers in Oncology

doi 10.3389/fonc.2021.622182

5,582 views
18 citations

Original Research

Published on 07 Nov 2022

Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer

in Molecular and Cellular Reproduction

Tova M. Bergsten
Sarah E. Levy
Katherine E. Zink
Hannah J. Lusk
Melissa R. Pergande
Stephanie M. Cologna
Joanna E. Burdette
Laura M. Sanchez

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2022.1042734

4,302 views
7 citations

Original Research

Published on 20 May 2024

Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment

in Pharmacology of Anti-Cancer Drugs

Jasmine Ebott
Julia McAdams
Chloe Kim
Corrine Jansen
Morgan Woodman
Payton De La Cruz
Christoph Schrol
Jennifer Ribeiro
Nicole James

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375421

4,178 views
12 citations

Case Report

Published on 25 Mar 2024

Case report: A case of high grade serous carcinoma of peritoneal origin

in Surgical Oncology

Yiming Liu
Sixian Wang
Yingchao Wu
Guowei Chen
Junling Zhang
Xin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1323650

3,568 views
1 citation

Original Research

Published on 17 Mar 2022

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models

in Pharmacology of Anti-Cancer Drugs

Victoria Heredia-Soto
Javier Escudero
María Miguel
Patricia Ruiz
Alejandro Gallego
Alberto Berjón
Alicia Hernández
Marta Martínez-Díez
Shuyu Zheng
Jing Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.862321

4,143 views
2 citations

Case Report

Published on 27 Mar 2024

Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation

in Gynecological Oncology

Mariko Peterson
David L. Kolin
Panagiotis A. Konstantinopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1357980

2,743 views

Case Report

Accepted on 30 Jan 2026

THORACOSCOPIC SECONDARY CYTOREDUCTIVE SURGERY FOR HIGH GRADE SEROUS OVARIAN CANCER – A CASE REPORT

in Surgical Oncology

Luigi Carlo Turco
Benedetta Alberghetti
Carlotta Francesca Cartia
Antonella Biscione
Giacomo Guidi
Filippo Maria Capomacchia
Andrea Droghetti

Frontiers in Surgery

180 views

Original Research

Published on 22 Apr 2024

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer

in Gynecological Oncology

Sarah J. Taylor
Robert L. Hollis
Charlie Gourley
C. Simon Herrington
Simon P. Langdon
Mark J. Arends

Frontiers in Oncology

doi 10.3389/fonc.2024.1389472

2,680 views
3 citations

Original Research

Published on 20 Aug 2024

Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer

in Gynecological Oncology

Snita Sinukumar
Dileep Damodaran
Deepika S.
Sanjay Piplani

Frontiers in Oncology

doi 10.3389/fonc.2024.1458019

2,425 views
3 citations

Original Research

Published on 17 Mar 2022

Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer

in Gynecological Oncology

Yali Fan
Jiandong Wang
Ziwei Fang
Stuart R. Pierce
Lindsay West
Allison Staley
Katherine Tucker
Yajie Yin
Wenchuan Sun
Weimin Kong

Frontiers in Oncology

doi 10.3389/fonc.2022.789450

6,363 views
20 citations

Case Report

Published on 21 May 2024

Case report: Axillary lymph node metastases from primary ovarian cancer: a report of two cases and literature review

in Surgical Oncology

Norlia Abdullah
Nadiah Rosly
Suria Hayati Md Pauzi
Aida Widure Mustapha
Yulianty Arifuddin

Frontiers in Oncology

doi 10.3389/fonc.2024.1384306

3,363 views
3 citations

Brief Research Report

Published on 19 Aug 2020

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer

in Pharmacology of Anti-Cancer Drugs

Ram N. Ganapathi
Eric J. Norris
Ashley P. Sutker
Kaitlin E. Klotz
Mahrukh K. Ganapathi

Frontiers in Oncology

doi 10.3389/fonc.2020.01354

3,904 views
5 citations

Original Research

Published on 19 Aug 2019

Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease

in Women's Cancer

Angela Santoro
Giuseppe Angelico
Alessia Piermattei
Frediano Inzani
Michele Valente
Damiano Arciuolo
Saveria Spadola
Antonino Mulè
Piercarlo Zorzato
Anna Fagotti

Frontiers in Oncology

doi 10.3389/fonc.2019.00778

22,496 views
52 citations

Case Report

Published on 06 Nov 2024

Case report: High grade serous fallopian tube carcinoma with rare NRG1 gene fusion presenting as widespread peritoneal carcinomatosis

in Gynecological Oncology

Anthony Crymes
Mark G. Evans
Tolulope Adeyelu
Jack Reid
Ifegwu O. Ibe
Matthew J. Oberley
Jill H. Tseng

Frontiers in Oncology

doi 10.3389/fonc.2024.1472725

2,766 views
1 citation

Mini Review

Published on 13 Apr 2021

T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review

in Cancer Immunity and Immunotherapy

Jessica W. Y. Wu
Sudiksha Dand
Lachlan Doig
Anthony T. Papenfuss
Clare L. Scott
Gwo Ho
Joshua D. Ooi

Frontiers in Immunology

doi 10.3389/fimmu.2021.672502

19,081 views
48 citations

Systematic Review

Published on 10 Feb 2022

Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update

in Gynecological Oncology

Frediano Inzani
Damiano Arciuolo
Giuseppe Angelico
Angela Santoro
Antonio Travaglino
Nicoletta D’Alessandris
Giulia Scaglione
Michele Valente
Federica Cianfrini
Antonio Raffone

Frontiers in Oncology

doi 10.3389/fonc.2022.814989

8,686 views
3 citations

Articles

Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer

Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer

Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment

Case report: A case of high grade serous carcinoma of peritoneal origin

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models

Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation

THORACOSCOPIC SECONDARY CYTOREDUCTIVE SURGERY FOR HIGH GRADE SEROUS OVARIAN CANCER – A CASE REPORT

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer

Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer

Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer

Case report: Axillary lymph node metastases from primary ovarian cancer: a report of two cases and literature review

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer

Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease

Case report: High grade serous fallopian tube carcinoma with rare NRG1 gene fusion presenting as widespread peritoneal carcinomatosis

T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review

Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update